Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Cross-reactivity among drugs: clinical problems.
Romano A, Guéant-Rodriguez RM, Viola M, Gaeta F, Caruso C, Guéant JL. Romano A, et al. Toxicology. 2005 Apr 15;209(2):169-79. doi: 10.1016/j.tox.2004.12.016. Toxicology. 2005. PMID: 15767031 Review.
Cross-reactivity among drugs is either mediated by immunologic mechanisms or not. ...The main clinical problem deriving from cross-reactivity among drugs is the compelling need to choose a potentially cross-reactive c …
Cross-reactivity among drugs is either mediated by immunologic mechanisms or not. ...The main clinical proble …
Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review.
Perrone MR, Artesani MC, Viola M, Gaeta F, Caringi M, Quaratino D, Romano A. Perrone MR, et al. Int Arch Allergy Immunol. 2003 Sep;132(1):82-6. doi: 10.1159/000073268. Int Arch Allergy Immunol. 2003. PMID: 14555862 Clinical Trial.
BACKGROUND: Adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are frequent, particularly among patients with chronic urticaria or asthma. ...CONCLUSIONS: Considering previous studies and our own data, rofecoxib was well tolerated by all of the 174 p …
BACKGROUND: Adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are frequent, particularly among patients with …